Free Trial

OptimizeRx (OPRX) Competitors

OptimizeRx logo
$5.15
-0.07 (-1.34%)
(As of 11/1/2024 ET)

OPRX vs. RMNI, WTRH, LLNW, MXCT, BWMN, OOMA, IBEX, BTOC, SHAP, and EGHT

Should you be buying OptimizeRx stock or one of its competitors? The main competitors of OptimizeRx include Rimini Street (RMNI), ASAP (WTRH), Limelight Networks (LLNW), MaxCyte (MXCT), Bowman Consulting Group (BWMN), Ooma (OOMA), IBEX (IBEX), Armlogi (BTOC), Spree Acquisition Corp. 1 (SHAP), and 8X8 (EGHT).

OptimizeRx vs.

Rimini Street (NASDAQ:RMNI) and OptimizeRx (NASDAQ:OPRX) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, community ranking, dividends, earnings, institutional ownership and analyst recommendations.

Rimini Street has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Rimini Street, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rimini Street$431.50M0.39$26.06M-$0.37-5.00
OptimizeRx$83.20M1.13-$17.57M-$1.00-5.15

Rimini Street presently has a consensus price target of $4.50, suggesting a potential upside of 143.24%. OptimizeRx has a consensus price target of $14.50, suggesting a potential upside of 181.55%. Given OptimizeRx's stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than Rimini Street.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rimini Street
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
OptimizeRx
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Rimini Street has a net margin of -7.87% compared to OptimizeRx's net margin of -21.53%. OptimizeRx's return on equity of -5.97% beat Rimini Street's return on equity.

Company Net Margins Return on Equity Return on Assets
Rimini Street-7.87% -83.26% 10.79%
OptimizeRx -21.53%-5.97%-4.42%

Rimini Street received 6 more outperform votes than OptimizeRx when rated by MarketBeat users. However, 63.36% of users gave OptimizeRx an outperform vote while only 63.22% of users gave Rimini Street an outperform vote.

CompanyUnderperformOutperform
Rimini StreetOutperform Votes
153
63.22%
Underperform Votes
89
36.78%
OptimizeRxOutperform Votes
147
63.36%
Underperform Votes
85
36.64%

In the previous week, Rimini Street had 8 more articles in the media than OptimizeRx. MarketBeat recorded 10 mentions for Rimini Street and 2 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.77 beat Rimini Street's score of 0.32 indicating that OptimizeRx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rimini Street
0 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
OptimizeRx
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Rimini Street has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500.

73.8% of Rimini Street shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 41.0% of Rimini Street shares are held by company insiders. Comparatively, 6.1% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Rimini Street beats OptimizeRx on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPRX vs. The Competition

MetricOptimizeRxBusiness services IndustryComputer SectorNASDAQ Exchange
Market Cap$94.36M$20.04B$23.97B$8.53B
Dividend YieldN/A2.58%2.75%4.14%
P/E Ratio-5.1519.72252.7915.18
Price / Sales1.136.103,725.0492.77
Price / CashN/A29.8832.0734.07
Price / Book0.745.146.985.02
Net Income-$17.57M$479.90M$670.43M$225.46M
7 Day Performance-5.68%-0.91%-0.32%0.37%
1 Month Performance-32.15%-3.40%0.65%3.57%
1 Year Performance-38.03%28.62%20.34%29.44%

OptimizeRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPRX
OptimizeRx
2.5855 of 5 stars
$5.15
-1.3%
$14.50
+181.6%
-36.4%$94.36M$83.20M-5.15100News Coverage
RMNI
Rimini Street
3.5252 of 5 stars
$1.77
+11.3%
$4.50
+154.2%
-22.9%$144.21M$431.50M-4.782,120Earnings Report
News Coverage
High Trading Volume
WTRH
ASAP
N/AN/AN/AN/A$19.35M$130.00M-0.091,034
LLNW
Limelight Networks
0.4711 of 5 stars
N/AN/AN/A$339.96M$217.63M-6.31556
MXCT
MaxCyte
2.9021 of 5 stars
$3.58
+1.1%
$8.67
+142.1%
+14.9%$372.30M$41.29M-10.53143Upcoming Earnings
News Coverage
BWMN
Bowman Consulting Group
3.6262 of 5 stars
$20.30
-3.5%
$40.10
+97.5%
-20.4%$369.56M$386.81M-27.072,000Upcoming Earnings
Short Interest ↓
News Coverage
OOMA
Ooma
1.4001 of 5 stars
$11.96
-3.8%
$14.50
+21.2%
+15.4%$333.12M$236.74M-62.951,221
IBEX
IBEX
2.846 of 5 stars
$17.96
-2.0%
$20.50
+14.1%
+8.7%$307.14M$508.57M9.7130,000Upcoming Earnings
BTOC
Armlogi
N/A$6.87
+15.3%
N/AN/A$285.79M$166.98M0.00N/AHigh Trading Volume
SHAP
Spree Acquisition Corp. 1
N/A$10.91
flat
N/AN/A$283.07MN/A0.00N/A
EGHT
8X8
2.5317 of 5 stars
$2.23
+2.8%
$2.93
+31.3%
-3.9%$278.48M$728.71M-4.461,948Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:OPRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners